Recent Developments in Liposome-Based Veterinary Therapeutics

Table 2

An overview of some of the liposome-based therapeutic systems studied in recent years with clinical significance for veterinary medicine. (For explanation of symbols, please refer to legend).

Species	Agent	Disease/condition	Reference
Dogs	Doxorubicin (thermosensitive liposomes)	Spontaneous canine tumours	[16]^■
Cats	Doxorubicin in conjunction with radiotherapy	Soft-tissue sarcoma	[17]
Dogs	HSA cell lysates	Canine hemangiosarcoma (HSA)	[23]^▲
Dogs	Endostatin DNA	Soft-tissue sarcoma	[24]^▲
Chickens	Salmonella fimbriae proteins	Salmonella enterica vaccine	[32]
Chickens	Inactivated APEC (avian pathogenic E. coli)	Avian colibacillosis vaccine	[34]^▲
Chickens	Newcastle disease virus	Newcastle disease vaccine	[35]^▲
Sheep	MIC3 protein from T. gondii	Toxoplasma gondii vaccine	[39]^▲
Green-cheeked conures	Butorphanol tartrate	Experimentally induced arthritic pain	[45]
Dogs	Hydromorphone	Postoperative pain	[46]
Horses	Diclofenac	Osteoarthritis pain	[48]

■Clinical trial. ^▲Pilot study or primary evaluation in listed species.